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ABSTRACT 
The endoplasmic reticulum chaperone gp96 is required for the cell surface expression of a narrow range 
of proteins, including toll-like receptors (TLRs) and integrins. To identify a more comprehensive 
repertoire of proteins whose cell surface expression is dependent on gp96, we developed plasma 
membrane profiling (PMP), a technique that combines SILAC labeling with selective cell surface 
aminooxy-biotinylation. This approach allowed us to compare the relative abundance of plasma 
membrane (PM) proteins on gp96-deficient versus gp96-reconstituted murine pre-B cells. Analysis of 
unfractionated tryptic peptides initially identified 113 PM proteins, which extended to 706 PM proteins 
using peptide pre-fractionation. We confirmed a requirement for gp96 in the cell surface expression of 
certain TLRs and integrins and found a marked decrease in cell surface expression of four members of 
the extended LDL receptor family (LDLR, LRP6, Sorl1 and LRP8) in the absence of gp96. Other novel 
gp96 client proteins included CD180/Ly86, important in the B-cell response to lipopolysaccharide. We 
highlight common structural motifs in these client proteins that may be recognised by gp96, including 
the beta-propeller and leucine-rich repeat. This study therefore identifies the extended LDL receptor 
family as an important new family of proteins whose cell surface expression is regulated by gp96. 
KEYWORDS gp96, plasma membrane, biotin, SILAC, LDLR, Sorl1, LRP6, LRP8, CD180 
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INTRODUCTION 
Gp96 (also known as gpr94 or HSP90b1) is a ubiquitously expressed chaperone and the only ER 
resident member of the HSP90 family.
1
 Gp96 has several biological functions, of which the best 
recognised is its role in the folding and assembly of membrane proteins of the secretory pathway. In the 
absence of gp96 these proteins are targeted for ER-associated degradation (ERAD).
1
 However, the 
chaperone activity of gp96 is selective, with targets including integrins, toll-like receptors (TLRs), 
insulin-like growth factors (IGFs), thyroglobulin and the platelet glycoprotein Ib-IX-V complex.
2-8
 The 
selectivity of gp96 as a chaperone is illustrated by the case of the integrin family.
3
 While many integrins 
require chaperoning by gp96, some - and -integrins are gp96 independent.
2,9
 The first reported gp96 
clients came from the immunoglobulin family.
10
 However, serum immunoglobulins are normal in mice 
with a B-cell selective gp96-depletion, suggesting that folding of immunoglobulins is gp96-
independent.
11
 Other than the presence of disulfide bonds, no common structural feature of gp96 clients 
has emerged.
12
 
 
To gain a more complete understanding of cell surface receptors whose expression is dependent on 
gp96, we developed an unbiased proteomics approach for the selective enrichment of plasma membrane 
proteins. Selective oxidation and aminooxy-biotinylation of sialylated PM glycoproteins, followed by 
off-line high pH reversed-phase HPLC (HpRP-HPLC) fractionation allowed the mass spectrometry 
identification of up to 700 PM proteins, as defined by gene ontology (GO) terms. Using this technique 
we performed a SILAC-based differential analysis of plasma membrane proteins whose expression is 
dependent upon gp96. A comparison of gp96-knockout and gp96-reconstituted murine pre-B cells
3,13
 
found that the cell surface expression of 29 proteins was decreased >3.0 fold in the absence of gp96. We 
confirmed the reported gp96 dependence of integrins 4, V, L, 2 and toll-like receptors TLR6 and 
TLR4, and the lack of dependence of the 6 and 1 integrins.
2-4,9,11
 We now report that gp96 is required 
for cell surface expression of four members of the LDLR family: (i) the founding member LDLR, which 
plays a central role in regulating the concentration of plasma LDL and when absent leads to familial 
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hypercholesterolaemia
14
 (ii) the Wnt signalling protein lipoprotein receptor-related protein-6 (LRP6) 
which participates with Frizzled proteins as coreceptors in Wnt signaling,
15
 (iii) the sortilin related 
receptor Sorl1 implicated in the pathogenesis of Alzheimer’s disease16 and (iv) LRP8 (apolipoprotein E 
receptor 2) required for neural development through Reelin signaling.
17
 None of the remaining six 
members of the LDLR family were detected by mass spectrometry. Our data suggest that LDL receptor 
family members are dependent on gp96 for optimal cell surface expression. 
 
MATERIALS AND METHODS 
Cells and cell culture 
All cell lines were derived from the murine pre-B-cell line 70Z/3, as described previously. The NF- B 
reporter cell line GTPT3 was engineered to express three NF- B-dependent markers for previous studies 
of IKK  mutants.
18
 GTPT3 cells were mutagenised with ICR191 (Sigma), and individual clones derived. 
The resulting M36 clone has two frameshift mutations in the ORF of gp96, resulting in production of a 
truncated non-functional protein.
13
 M36/gp96+ cells were derived by stable transduction of M36 cells 
with gp96.
13
 M36 and M36/gp96+ cells were used for the majority of the analysis in our study. The 
E4.126 clone was independently derived from 70Z/3 cells by ICR191 mutagenesis, and also carries two 
frameshifting mutations in gp96.
3,13
 All cells were grown in SILAC RPMI 1640 medium (Thermo 
Pierce, Cramlington, UK) supplemented with 10% dialysed foetal calf serum (FCS) (JRH Biosciences, 
Kansas, USA), Penicillin at 100 units/ml, Streptomycin at 0.1 mg/ml (Sigma, Dorset, UK) and 50 M 
Mercaptoethanol (Sigma). Media was supplemented with either light (Arg 0, Lys 0, Sigma) or heavy 
(Arg 10, Lys 8, Cambridge Isotope Laboratories, MA, USA) amino acids at 50 mg/l and L-proline at 
280 mg/l.
19
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Figure 1. Plasma membrane profiling workflow. Heavy and light labelled cells are mixed early in the 
procedure and sialylated glycoproteins oxidised and biotinylated. The enriched glycoproteins are 
digested, and bound N-linked glycopeptides released using PNGase F.  Eluates are prepared for LC-
MSMS. 
Preparation of PM proteins using aminooxy-biotin 
We have optimized our procedure
20
 for enrichment of PM proteins for proteomic analysis, as 
described below (Figure 1). M36 cells were grown in light media, and M36/gp96+ cells in heavy media 
for seven divisions. 1.2 × 10
8
 of each cell type were pooled in a 1:1 ratio and washed twice in ice-cold 
PBS pH 7.4 (Sigma). All the following steps were performed on ice. An oxidation/biotinylation mix
21
 
comprising 1 mM sodium meta-periodate, 100 mM aminooxy-biotin (Biotium Inc, Hayward, CA) and 
10 mM aniline (Sigma) in ice-cold PBS pH 6.7 was vortexed with aniline added immediately prior to 
vortexing. Surface sialic acid residues were oxidized then biotinylated by resuspending cells in 6 ml mix 
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(1 ml per 4 × 10  cells) with rocking in the dark. The oxidation reaction was quenched by glycerol to 1 
mM final concentration. Cells were washed once in PBS pH 7.4/5% (v/v) FCS, then once in PBS pH 
7.4. PBS contained 1 mM CaCl2 and 0.5 mM MgCl2. Biotinylated cells were centrifuged at 400 g at 4°C 
for 5 min, and the resulting cell pellet was re-suspended and incubated at 4 °C for 30 min in lysis buffer 
(1% Triton X-100 (high purity, Thermo), 150 mM NaCl, 1x protease inhibitor (complete, without 
EDTA (Roche)), 5 mM iodoacetamide (Sigma), 0.1 mg/ml PMSF and 10 mM Tris-HCl pH 7.6). Nuclei 
were removed by centrifugation at 4 °C, initially at 2,800 g then twice at 16,000 g. Biotinylated proteins 
were enriched by incubating for 2 h at 4 
o
C with 144 l high affinity streptavidin agarose beads (6 l 
beads per 10
7
 input cells, Pierce). Extensive washing was performed using a vacuum manifold and Snap 
Cap spin columns (Pierce). All washes or incubations in the following description were with 600 l 
buffer; all centrifugation steps were performed at 1,000 g for 1 min. Beads were initially washed 20 × 
with lysis buffer, 20 × with PBS/0.5% (w/v) SDS and incubated for 20 min at RT with PBS/0.5% (w/v) 
SDS/100 mM DTT, then centrifuged. Further washing was performed 20 × with UC buffer (6 M urea, 
100 mM Tris-HCl pH 8.5), followed by alkylation for 20 min at RT with UC buffer containing 50 mM 
iodoacetamide. Beads were washed (20 × per step with centrifugation after each step), using UC buffer, 
5 M NaCl, 100 mM Na2CO3, PBS then water, resuspended in 400 l 50 mM NH4HCO3 containing 5 g 
modified sequencing grade trypsin (Promega), then transferered to a protein LoBind tube (Eppendorf), 
where biotinylated glycoproteins were digested on-beads overnight. Beads were transferred to a Snap 
Cap spin column and tryptic peptides collected by centrifugation at 1,000 g for 1 min. Beads were rinsed 
once with 50 mM NH4HCO3, and tryptic fractions pooled. 10% of the resultant digest was desalted and 
concentrated by StageTip
22
 for immediate analysis. The remaining tryptic peptide sample was 
fractionated by HpRP-HPLC (see below). To elute glycopeptides, beads were washed with PBS, then 
water, then G7 buffer (New England Biolabs, Hitchin, UK). Beads were incubated for 5 h in 400 l G7 
buffer containing 30,000 units of glycerol free PNGase (New England Biolabs). Glycopeptides were 
collected by centrifugation at 1,000 g for 1 min, beads were washed once with G7 buffer, and eluates 
pooled and concentrated on a StageTip.
22
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Biotinylation was confirmed by staining aliquots of cells prior to and after biotinylation with 
streptavidin-allophycocyanin (eBioscience, CA, USA). The incorporation of heavy label was checked by 
analysis of a lysate of 3 × 10
6
 heavy labeled cells, generated using SDS/DTT/Tris (SDT) buffer and 
Filter Aided Sample Processing (FASP).
23
 Incorporation was >98% for both arginine and lysine-
containing peptides. 
 
High pH reverse-phase high pressure liquid chromatography (HpRP-HPCL) fractionation and 
mass spectrometric analysis 
A total of 100 µg of tryptic peptide was subjected to HpRP-HPLC fractionation using a Dionex 
Ultimate 3000 powered by an ICS-3000 SP pump with an Agilent ZORBAX Extend-C18 column (4.6 
mm × 250 mm, 5 µm particle size). Mobile phases (H20, 0.1% NH4OH or MeCN, 0.1% NH4OH) were 
adjusted to pH 10.5 with the addition of formic acid and peptides were resolved using a linear 40 min 
0.1%-40% MeCN gradient over 40 min at a 400 µl/min flow rate and a column temperature of 15 °C. 
Eluting peptides were collected in 15 s fractions. 
Fractions were dried down using an Eppendorf Concentrator and re-suspended in 8 µl MS solvent (3% 
MeCN, 0.1% TFA). Fractions 25 to 152 inclusive were analysed and in each case 3 µl was injected and 
subjected to LC-MSMS using a NanoAcquity uPLC (Waters, MA, USA) coupled to an LTQ-OrbiTrap 
XL (Thermo, FL, UA). Peptides were eluted using a gradient rising from 7 to 25% MeCN by 30 min, 
40% MeCN by 39 min and 85% MeCN by 42 min. MS data was acquired between 400 and 2000 m/z at 
60,000 fwhm with lockmass enabled (445.120025 m/z). CID spectra were acquired in the LTQ with 
MSMS switching operating in a top 6 DDA fashion triggered at 500 counts.  Unfractionated peptides 
were eluted using a gradient rising from 3 to 25% MeCN by 90 min, 40% MeCN by 110 min and 85% 
MeCN by 115 min. Spectra were acquired using the same MS parameters. 
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Database searching and data processing 
Raw MS files were processed in parallel using MaxQuant versions 1.0.13.13 and 1.1.1.14.
24,25
 Data 
were searched against the International Protein Index mouse database release 3.68 using MASCOT 
Daemon 2.3.2 and Andromeda version 1.1.1.14.
25
 Fragment ion tolerance was set to 0.5 Da with a 
maximum of 2 missed tryptic cleavage sites. Carbamidomethyl cysteine was defined as a fixed 
modification, oxidised methionine, N-terminal acetylation and deamidation (NQ) were selected as 
variable modifications. Reversed decoy databases were used and the false discovery rate for both 
peptides and proteins were set at 0.01. Protein quantitation utilised razor and unique peptides and 
required a minimum of 2 ratio counts and normalized protein ratios reported. Peptide re-quantify was 
enabled in all analyses apart from where indicated. Significance A values were calculated and Gene 
Ontology Cellular Compartment (GOCC) terms added using Perseus version 1.1.1.13 (downloaded from 
http://maxquant.org). 
To assess the number of PM proteins identified, we summed the proteins with GOCC terms plasma 
membrane (PM), cell surface but not PM (CS) and extracellular but not PM/CS (XC). We previously 
identified a subset of proteins annotated by GO as integral to the membrane, but with no subcellular 
assignment and a short GOCC (ShG) term (a 4-part term containing the terms ‘integral to membrane’ 
‘intrinsic to membrane’, ‘membrane part’, ‘cell part’ or a 5-part term containing ‘membrane’ in addition 
to these terms).
20
  Where a majority of proteins identified from a given sample are annotated 
PM/CS/XC, it is likely that a substantial proportion of the proteins with a short GOCC term are also 
integral PM proteins – including these proteins provides a useful upper estimate of the number of 
identified PM proteins. 
 
Structural annotation and protein-protein interactions 
We used the method of Adachi et al
26
 to determine statistically enriched protein domains in our 
dataset. Briefly, Interpro (release 34.0) was used to annotate protein structural domains, and Cytoscape
27
 
plugin BiNGO
28
 was used for domain enrichment analysis. The test dataset was the InterPro annotations 
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of all proteins we identified by ≥2 peptides and found downregulated >3 fold in the absence of gp96. 
The reference set was the InterPro annotations of all proteins we identified by ≥2 peptides. The InterPro 
ontology was derived from the interpro.xml file, InterPro release 34.0 
(ftp://ftp.ebi.ac.uk/pub/databases/interpro/). The enrichment analysis was performed using a 
Hypergeometric test, and we selected all InterPro domains that were significant with p<0.001 after 
correcting for multiple term testing by Benjamini and Hochberg false discovery rate. Fold enrichment 
was calculated by comparing the test set against the reference set.  
Cytoscape version 2.8.2 (www.cytoscape.org) was used with the Mimi plugin
29
 to determine the 
known interactions of proteins down- or up-regulated > 3 fold in the absence of gp96. 
 
Flow cytometry 
All of the following steps were performed on ice to prevent receptor internalization. Cells were 
washed in ice-cold PBS pH 7.4 containing 1 mM CaCl2 and 0.5 mM MgCl2 (Sigma), incubated for 15 
min with 10 mg/ml Fc block (Vivaglobulin, CSL Behring UK Ltd) and stained (30 min, 4 
o
C) using the 
following anti-mouse monoclonal antibodies: anti-CD44 FITC, anti-CD18 PE, anti-H2Kb PE (Caltag 
Laboratories, CA, USA) and unconjugated anti-LDLR (R and D systems, Abingdon, UK). Cells were 
washed in PBS. Cells that had been stained with the unconjugated anti-LDLR primary antibody were 
stained (30 min, 4 
o
C) with anti-rat Cy5 (Invitrogen, CA, USA) then washed with PBS. Cells were fixed 
in 1% paraformaldehyde and analysed on a FACS Calibur using Cellquest (BD Pharmingen) and 
FCSPress v1.3 (www.fcspress.com). 
 
RESULTS 
Enrichment of plasma membrane proteins by PMP  
To identify proteins whose cell surface expression was dependent on gp96 we further developed and 
improved our plasma membrane enrichment technique, termed ‘plasma membrane profiling’ (Figure 
1).
20
 Aminooxy-biotinylated PM proteins were prepared from M36 cells (light media) and M36/gp96+ 
 11 
cells (heavy media), as described above. After capture on streptavidin beads, proteins were digested with 
trypsin. 10% of this tryptic peptide sample was desalted and concentrated to confirm enrichment of PM 
proteins. We identified 135 proteins, of which 89 were annotated ‘plasma membrane’ (PM). An 
additional 2 proteins were annotated ‘cell surface’ (CS), and 3 proteins ‘extracellular’ (XC), giving a 
total of 94 PM/CS/XC proteins, representing 70% of all identified proteins with a GOCC annotation 
(Table 1). Including the 19 proteins with a ‘short GO’ (ShG) annotation (described above) gave a useful 
upper estimate of the number of identified PM proteins, 113 PM/CS/XC/ShG proteins (84%). A total of 
7 proteins were annotated ‘nucleus’, 4 of which were additionally annotated PM. The 3 nuclear proteins 
not annotated PM are likely to represent contaminants (Table 1). 
 
HPLC fractionation of tryptic peptides results in a substantial increase in identified plasma 
membrane proteins. 
As a significant number of PM proteins were identified at high purity from the unfractionated tryptic 
peptide sample, we performed HpRP-HPLC fractionation on the remaining 90% of sample. 128 
fractions were analysed (Figure S1, Supporting Information), and this data processed in parallel with the 
PNGase fraction using MaxQuant version 1.0.13.13 (referred to as ‘Mascot’) and MaxQuant version 
1.1.1.14 (referred to as ‘Andromeda’). Fractionation substantially increased the total and PM protein 
identifications – combining the Mascot and Andromeda data, a total of 563 proteins annotated 
PM/CS/XC and 706 proteins annotated PM/CS/XC/ShG were identified (Table 1, Table S1, Supporting 
Information). 450 proteins annotated PM/CS/XC and 565 proteins annotated PM/CS/XC/ShG were 
quantified, out of a total of 1271 quantified proteins. 
46 of the 1271 proteins were downregulated >3 fold (Table S2, Supporting Information), 29 of which 
were identified by ≥2 peptides (Figure 2 and Table 2). Of these 29 proteins, 24 were annotated 
PM/CS/XC and 26 PM/CS/XC/ShG (93%). 
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Figure 2. Scatterplot of all proteins identified by ≥2 peptides. Fold change (x-axis) is shown as log2, and 
summed ion intensity (y-axis) is shown as log10. Significance A values were calculated using Perseus 
version 1.1.1.13. 
Plasma membrane profiling confirms the critical role of gp96 in cell surface expression of 
integrins and TLRs 
Our data was validated by confirming the dependence on gp96 for cell surface expression of integrins 
4, V, L, and 2,
2,3,9,11
 and gp96 independence of integrins 1, 6 and 5
2
 (Table 2 and Table S1, 
Supporting Information). Furthermore, flow cytometric analysis of integrin 2 (CD18) demonstrated 
decreased cell surface expression to the level of the unstained control in two independently derived 
gp96-deficient cell lines (Figure 3). We also showed that integrin 9 is gp96 dependent (Table 2). The 
normal cell surface expression of integrin 1 and decreased expression of integrin 3 in gp96-deficient 
cells contrasts with a previous report.
2
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Figure 3. Flow cytometry confirms that LDLR is gp96 dependent. (a) M36 and M36/gp96+ cells or (b) 
the independent gp96 knockout E4.126 and control GTPT3 cells were stained with monoclonal 
antibodies against the indicated cell surface targets. At least three replicate stains were performed for 
each cell surface target, confirming the above observations (data not shown). 
 
Two TLRs were identified. Surface localization of TLR6 was dependent on gp96 (Table 2), as 
reported.
3,4,30
 TLR4 was identified by two peptides (Table S1, Supporting Information) however no 
protein ratio was reported by either Mascot or Andromeda. One of the two peptides was quantified by 
both algorithms, with fold downregulation ratios of 34.2 (Mascot) and 14.1 (Andromeda), suggesting 
that surface expression of TLR4 is dependent on gp96, as reported.
3,4
 
Several proteins were not dependent on gp96 for their surface expression, including CD44, ICAM1, 
CXCR4, IL7R as well as MHC class I allotypes
3,11
 and this could be confirmed by flow cytometry for 
CD44 and H2-Kb (Figure 3). 
Finally, gp96 (Endoplasmin) was detected at the PM in M36/gp96+ cells and showed decreased 
plasma membrane expression (3.8 - 5.3 fold) in M36 cells (Table 2). This corresponds to western 
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blotting analysis of gp96 from M36 lysates which showed a truncated protein at low abundance.
13
 The 
two frameshifting mutations in the ORF of gp96 in M36 cells explain the loss of wild-type protein.
13
 
 
Downregulation of LDLR family members in gp96 deficient cells 
Most notable of the novel proteins whose cell surface expression is decreased in the absence of gp96 
were 4 proteins of the extended LDLR family: the LDLR itself (25.2 - 35.0 fold), LRP6 (21.9 – 65.6 
fold), Sorl1 (29.5 – 32.3 fold) and LRP8 (apolipoprotein E receptor 2) (5.4 fold). The other 6 members 
of the LDLR family (VLDLR, MEGF7, LRP1, LRP1B, LRP2, LRP5) were not detected. This likely 
reflects either low expression levels in pre-B cells, or solubility problems since these proteins are large, 
ranging from 211 – 522 kDa, and may therefore not be efficiently enriched by our PMP approach. The 
absolute dependence of cell surface LDLR expression on gp96 was readily confirmed by flow cytometry 
in both gp96 deficient cells (M36 and E4.126) (Figure 3). No other antibodies suitable for flow 
cytometry were available for other mouse protein family members. Given the structural similarities of 
other members of the LDLR family to LDLR and ApoER2, it seems likely that these six proteins are 
also gp96-dependent, though confirmation is required given the selectivity of gp96 for certain -
integrins. 
All members of the LDLR family and more distantly related receptors are characterized by the 
presence of at least one YWTD-motif containing beta-propeller domain, with flanking EGF-like 
cysteine-rich repeats.
12
 Both beta-propellers and EGF repeats have been identified as structural motifs 
present in other known gp96 clients. All -integrins contain a single seven-bladed beta-propeller, and -
integrins contain four cysteine-rich EGF repeats
31
 Amongst the other proteins dependent on gp96 for 
cell surface expression, attractin contains a beta-propeller (of the Kelch-repeat type rather than WD-
repeat type); Laminin alpha 5, attractin, N-glycan processing alpha-mannosidase IIx and EGF-containing 
fibulin-like extracellular matrix protein 1 contain EGF-like domains (Table 2). 
To determine which protein structures were over represented within the downregulated proteins as 
compared to all proteins identified by ≥2 peptides, we used the method of Adachi et al26 Significantly 
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enriched (p<0.001) protein domains or repeats were part of one of three structures: the beta-propeller, 
the leucine-rich repeat, or  integrin (Figure 4).  All -integrins and all members of the extended LDLR 
family contain -propeller motifs, suggesting that the beta-propeller and leucine-rich repeat may require 
gp96 for proper folding. However, there must be further complexity as some -integrins containing a -
propeller, and some TLR proteins containing the leucine-rich repeat are not dependent on gp96 for cell 
surface expression. 
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Figure 4. Fold enrichment of structures over-represented (p<0.001) in proteins downregulated in the 
absence of gp96 (Table 2), in comparison to all proteins identified by ≥2 peptides.  
 
CD180/Ly86 is a novel gp96 client 
In addition to LDLR family members, CD180 (RP105, Ly78) and Ly86 (MD1) both show decreased 
cell surface expression in the absence of gp96 (Table 2). CD180 is related to TLRs, contains leucine-
rich repeats
32,33
 and binds Ly86 (MD1).
34
 Gp96 may be required for CD180/MD1 complex assembly, by 
analogy to TLR4/MD2, as in the absence of gp96, TLR4 and MD2 cannot associate.
3
 Together 
CD180/Ly86 affect the immune response to lipopolysaccharide (LPS) by interfereing with an LPS-
derived signal delivered through the CD14-MD2-TLR4 complex.
35
 Additional LRR-containing proteins 
downregulated in gp96-deficient cells include: Leucine-rich repeat-containing protein 4C, Extracellular 
leucine-rich repeat and fibronectin type-III domain-containing protein 1, Adhesion molecule with Ig like 
domain 1, Leucine-rich repeats and immunoglobulin-like domains protein 2 (Table 2). 
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Other novel gp96 clients or interacting partners 
Ly86 may show decreased cell surface expression in gp96 deficient cells due to interaction with its 
LRR containing partner, CD180. To investigate whether the surface localisation of some proteins was 
aberrant because their binding partners are dependent on gp96 we searched all proteins identified by ≥2 
peptides, down- or up-regulated >3 fold (Table 2) using Cytoscape 2.8.2 to identify interacting partners 
(Figure S2, Supporting Information). Fibronectin is a ligand for integrin V/ 3,
36
 which might explain 
its downregulation (19.6 – 39.8 fold) in gp96 deficient cells. 
 
Correspondence of Mascot and Andromeda ratios 
Protein ratios generally corresponded well when data were processed using either Mascot or 
Andromeda (Table S1, Supporting Information) except when proteins were downregulated >3 fold, in 
which case the ratios generated using either software corresponded less well (Table 2 and Table S2, 
Supporting Information). Gp96 is critical for proper folding and functional expression of a number of 
integrins and TLRs; in gp96-deficient cells, these proteins are minimally expressed at the cell surface as 
assessed by flow cytometry.
3,5
 An optional step in the MaxQuant workflow is the ‘re-quantify’ strategy 
where ratios are calculated for precursors not assembled into SILAC pairs. This strategy is useful for 
quantifying low abundance peptides with high ratios, where one of the SILAC partners is at or below 
noise level,
24
 as is likely here for light labeled peptide derived from gp96 cell surface clients (M36 
cells). When we re-processed data with re-quantify turned off, there was much better correspondence 
between Mascot and Andromeda ratios (Figure S3, Supporting Information) albeit with a reduced 
number of quantified proteins. 
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DISCUSSION 
We developed plasma membrane profiling to compare the relative abundance of plasma membrane 
proteins in gp96-deficient versus gp96-reconstituted murine pre-B cells. We identified 706 PM proteins 
and found a requirement for gp96 in the cell surface expression of 29 of these proteins, including 
integrins, TLRs, and four members of the extended LDL receptor family (LDLR, LRP6, Sorl1 and 
LRP8). Our data indicates that gp96 is required for assembly of this functionally important class of 
proteins and suggests that it may be required to chaperone folding of some beta-propeller domains and 
leucine-rich repeats. 
Our enrichment for PM proteins using PMP compares well with other reports for plasma membrane 
protein preparations. For example, sucrose density gradient with 2-phase partitioning identified 428 
proteins from rat liver with 67% showing plasma membrane annotation.
37
 Cationic silica microbeads 
identified a total of 450 proteins from lung tissue with 81% plasma membrane annotation.
38
 We 
previously used cationic silica microbeads to enrich PM proteins, to determine novel substrates of the 
MARCH9 transmembrane E3 ligase
39
 and identified 157 PM proteins from an immortalised B-
lymphocyte cell line (16% of identified and annotated proteins). In our experience, this technique is less 
reliable than the aminooxy-biotin, giving lower yields and purity of plasma membrane proteins. In 
comparison to the other techniques tried, including crude membrane preparation, biotinylation of surface 
proteins with N-hydroxysulfosuccinimydyl-S,S-biotin and cationic silica microbeads, PMP gives us the 
best PM protein enrichment, the greatest number of PM protein identifications and best reproducibility 
between biological repeats.
20 
Cell surface capture (CSC) with biocytin hydrazide ligation of oxidized 
cell surface glycoproteins identified 96-341 proteins, of which 95% were present at the cell surface, as 
defined by the presence of at least one transmembrane or GPI anchor domain, a consensus glycosylation 
motif and an asparagine to aspartic acid deamidation site.
40
 A major advantage of PMP over CSC is the 
potential for increased protein sequence coverage and thus improved quantitative accuracy. Whereas 
CSC identified 1 - 3 glycopeptides per protein identified, in this study and previous, we identify 1 - 95 
peptides per protein. Other potential advantages of PMP using aminooxy-biotin over CSC with biocytin 
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hydrazide include the more stable product formation with the oxime ligation of aminooxy-biotin to cell 
surface aldehyde compared to the hydrazone ligation of biocytin hydrazide.
41
 The use of aniline as a 
catalyst enables use of aminooxy-biotin at relatively low concentration (100 M).
21
 
Following fractionation of the tryptic peptide sample, the percentage of proteins annotated PM/CS/XC 
fell from 70% to 35%. The increased identification of non-PM contaminants seen following high 
resolution fractionation suggests that contaminants form a minor part of the total protein content and 
highlights the efficiency of PM protein enrichment. Some of these contaminants might include proteins 
endogenously biotinylated at low level such as histones.
42
 The decreased percentage of proteins 
annotated PM/CS/XC in the fractionated sample also suggests that a proportion of the 143 proteins 
annotated ‘short GO’ may not be of PM origin. Curation of the murine GO database is however likely to 
be incomplete – for example, protein S100-A14 (Table S2, Supporting Information) was not annotated 
with GOCC terms by Perseus, but resides at the plasma membrane.
43
 
An essential role for gp96 in the cell surface expression of four of the ten members of the extended 
LDLR family adds these functionally and clinically important proteins to the integrins and TLRs in their 
requirement for gp96 for cell surface expression. Cellular cholesterol uptake is likely to be significantly 
diminished when cell surface expression of LDLR and other family members is reduced, and may 
explain the observed increase in proteins implicated in cholesterol metabolism in gp96-deficient cells 
(Table S1, Supporting Information, Table 2). These include scavenger receptor class B type I 
(upregulated 1.9 fold) which mediates the bidirectional transfer of cholesterol between cells and HDL 
cholesterol,
44
 hydroxymethylglutaryl-CoA synthase (Hmgcs1, upregulated 1.8 fold) which condenses 
acetyl-CoA with acetoacetyl-CoA to form HMG-CoA, the substrate for HMG-CoA reductase,
45
 
acetoacetyl-CoA synthetase and fatty acid synthase. Together these proteins may compensate for the 
reduction in cellular cholesterol uptake through the induction of alternative uptake or synthesis 
pathways. In addition, the mitochondrial/peroxisomal protein delta(3,5)-delta(2,4)-dienoyl-CoA 
isomerase (Ech1) was upregulated 4.1 fold in gp96 deficient cells (Table 2) – Ech1 acts in the 
alternative pathway for the beta-oxidation of unsaturated fatty acids, a source of acetyl-CoA.
46
 Increased 
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Ech1 expression might also provide acetyl-CoA as a substrate for Hmgcs1 and cholesterol synthesis, 
although other metabolic pathways could also generate this important intermediate. 
 
Since gp96 appears likely to play a key role in chaperoning the assembly of members of the extended 
LDLR, integrin and TLR protein families, are there shared structural features which shed light on the 
protein domains recognized by this chaperone and explain its selectivity? A key candidate here is the 
beta-propeller domain, which is formed from twisted -sheet structural repeats arranged toroidally 
around a central axis. The extracellular domain of α-subunit integrins contains a seven-bladed beta-
propeller which complexes with the I/A domain to form the ligand-binding head of the integrin.
47
 All 
members of the extended LDLR family share the same six-bladed beta-propeller domain, formed by six 
contiguous YWTD repeats. The core members of this family share further structural features, with 
ligand-binding cysteine-rich repeats followed by the beta-propeller, flanked by EGF-like cysteine-rich 
repeats.
48
 While these domains can be found individually in other proteins, it is only in the LDLR family 
that they coexist in the same protein.
49
 Clearly, not all propeller domain-containing proteins require 
gp96 for correct folding, but the unique interface between the propeller and adjacent modules may 
require gp96-assisted assembly. LDLR family members also have a specific requirement for the 
molecular ER chaperone boca (Drosophila melanogaster), and its mammlian orthologue Mesd, for 
folding and trafficking to the cell surface.
50-52
 In the absence of this chaperone they are retained in the 
ER, where gp96 is also most abundant. Boca/mesd is specifically required for maturation of the LDLR 
family beta-propeller/EGF modules,
53-55
 and it will therefore be interesting to determine whether Mesd 
interacts with gp96, and the relative roles of these different chaperones in LDLR assembly. It will also 
be necessary to confirm biochemically that the changes we observe in surface expression of LDLR 
family members are due to the absence of specific gp96 chaperone activity, as opposed to changes in 
transcription or translation of individual client genes. As the known functions of gp96 include 
chaperoning the folding of proteins, targeting of misfolded proteins to ERAD and storing calcium
1
, 
transcriptional effect would seem unlikely. The known gp96 clients, integrins and TLRs, fail to reach the 
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cell surface in the absence of gp96 due to misfolding
1-8
 – it is therefore likely that LDLR family 
members are similarly affected in the absence of gp96. 
 
The TLRs play a critical role in innate immunity and are type I transmembrane proteins with common 
structural features, including an N-terminal ectodomain containing multiple leucine-rich repeats for 
ligand binding, a short helix embedded in the membrane and a C-terminal cytosolic tail containing the 
Toll-interleukin-1 receptor (TIR) domain for recruiting signaling adaptors. Though not containing any 
beta-propeller domains, the widespread, structural leucine-rich repeat of 20-30 amino acids has a 
characteristic repetitive sequence pattern, built from tandem repeats to form curved solenoid structures, 
particularly well suited for protein-protein interactions.
56
 A possible role for gp96 may therefore be 
chaperoning the assembly of proteins with repeating units, such as repeated leucine-rich repeats, or 
repeated subunits of a beta-propeller. Gp96-deficient (M36 and E4.126) cells are resistant to infection by 
vesicular stomatitis virus (VSV) and viruses pseudotyped with VSV-G
13
 suggesting that one or more of 
the extended LDLR family, or indeed other gp96-dependent proteins identified in this analysis may be 
the receptor for VSV-G.  
 
In summary, Gp96 is required for cell surface expression of at least four members of the extended 
LDL receptor family, as well CD180/Ly86 and most integrins and TLRs. Amongst the proteins whose 
cell surface expression was gp96 dependent, we found a significant enrichment for beta-propeller and 
leucine rich repeats, suggesting an important role of gp96 in the folding of these modules. 
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Table 1. Proteins enriched using PMP were identified by LC-MS/MS and their subcellular location 
inferred from GOCC terms. 
  
Un-      
fractionated 
All fractions      
Mascot 
All fractions      
Andromeda 
All 
fractions      
combined 
Total proteins identified 135 1709 1551 1826 
Total proteins quantified 93 1181 1137 1271 
Annotations:         
Membrane 127 1352 1241 1433 
Plasma membrane or Cell surface (PM/CS) 91 481 452 509 
Extracellular but not PM/CS (XC) 3 48 39 54 
Short GO description (ShG) 19 141 129 143 
Nuclear but not PM/CS/XC/ShG 3 352 318 377 
Total PM/CS/XC 94 529 491 563 
Total PM/CS/XC/ShG 113 670 620 706 
% PM/CS/XC of all identified + annotated proteins 70% 34% 35% 35% 
% PM/CS/XC/ShG of all identified+annotated proteins 84% 44% 44% 43% 
 
Numbers of proteins are shown with the indicated annotations. The percent PM/CS/XC is calculated 
as (PM/CS/XC annotations / (total protein identifications – proteins without GOCC annotation)). 
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Table 2. Proteins identified by ≥ 2 peptides and down- or up-regulated >3 fold in gp96 deficient cells. 
    Ratio Peptides % coverage Significance A GOCC Structure 
IPI number Protein Name Mct Adr Mct Adr Mct Adr Mct Adr M P C X N S P Lrr Egf Ig 
 
DOWNREGULATED 
                  
IPI00121334 Integrin alpha-4 113.2 49.2 12 10 13.7 11.5 9.2E-21 6.1E-12 M P C 
   
P 
   
IPI00828582 Integrin alpha L 73.3 43.3 27 25 28.4 26 2.0E-17 2.9E-11 M P 
    
P 
   
IPI00271594 Low-density lipoprotein receptor-related protein 6 65.6 21.9 12 10 9.2 7.6 1.3E-16 5.2E-08 M P 
    
P 
 
Egf 
 
IPI00130117 Integrin alpha 9 63.5 37.8 10 10 11.8 12 2.1E-16 1.4E-10 M P 
    
P 
   
IPI00343568 CD180 antigen 52.5 22.4 9 8 19.2 16.8 4.3E-15 4.2E-08 M P 
     
Lrr 
  
IPI00785217 Low-density lipoprotein receptor 35.0 25.2 22 16 27.8 22.5 1.7E-12 1.3E-08 M P 
 
X 
  
P 
 
Egf 
 
IPI00553419 Desmoplakin 32.7 9.9 9 5 3.2 2 4.4E-12 5.4E-05 M P 
        
IPI00776230 Sortilin-related receptor 32.3 29.5 9 8 5.5 4.9 5.2E-12 2.4E-09 M 
  
X 
  
P 
 
Egf 
 
IPI00320605 Integrin beta-2 26.3 25.1 23 21 37.5 35.5 7.9E-11 1.3E-08 M P C 
     
Egf 
 
IPI00918724 Latrophilin-1 24.6 24.0 2 3 1.6 2.4 1.9E-10 2.0E-08 M P 
        
IPI00229475 Junction plakoglobin 21.8 17.2 9 8 14.1 12.6 8.2E-10 5.4E-07 M P 
  
N 
     
IPI00113539 Fibronectin 19.6 39.8 5 2 2.4 1.1 3.0E-09 8.0E-11 M P 
 
X 
      
IPI00128026 Lymphocyte antigen 86 18.2 
 
2 1 16.7 11.1 7.1E-09 
    
X 
     
Ig 
IPI00857195 Integrin alpha V 17.3 17.1 28 27 33.6 32.3 1.3E-08 5.6E-07 M P 
    
P 
   
IPI00266264 Integrin beta-3 16.8 15.8 20 18 32.7 28.2 1.7E-08 1.1E-06 M P 
      
Egf 
 
IPI00468203 Annexin A2 13.1 9.7 3 3 11.5 11.5 2.4E-07 6.4E-05 M P 
 
X 
      
IPI00309419 Leucine-rich repeat-containing protein 4C 11.0 15.1 2 3 3.8 5.3 1.4E-06 1.7E-06 M P 
     
Lrr 
 
Ig 
IPI00405227 Vinculin 11.0 13.0 4 2 4.5 2.4 1.5E-06 6.4E-06 M P 
        
IPI00227288 Extracellular LRR and Fn type-III domain protein 1 10.3 10.1 5 4 8.2 7 2.6E-06 4.5E-05 M 
    
S 
 
Lrr 
  
IPI00828535 Attractin 8.3 8.2 4 5 4 4.9 1.9E-05 0.0002 M P 
    
P 
 
Egf 
 
IPI00224294 N-glycan processing alpha-mannosidase IIx 7.1 6.6 2 3 2.3 3.1 6.6E-05 0.0009 
        
Egf 
 
IPI00223457 EGF-containing fibulin-like extracellular matrix protein 1 6.5 
 
2 
 
4.7 
 
0.0001 
    
X 
    
Egf 
 
IPI00648457 Adhesion molecule with Ig like domain 1 5.8 12.5 3 2 5 3.2 0.0003 8.5E-06 M 
    
S 
 
Lrr 
 
Ig 
IPI00410868 Low-density lipoprotein receptor-related protein 8 
 
5.4 2 2 2.2 2.2 
 
0.0031 M P 
 
X 
  
P 
 
Egf 
 
IPI00380390 Toll-like receptor 6 4.5 33.1 4 3 5.2 4.8 0.0019 6.6E-10 M P 
     
Lrr 
  
IPI00480329 E1A-binding protein p400 
 
4.4 1 2 0.7 1.1 
 
0.0096 M 
   
N 
     
IPI00129526 Endoplasmin 3.8 5.3 6 5 8.9 7.7 0.0047 0.0035 M P 
        
IPI00605095 Leucine-rich repeats and Ig-like domains protein 2 3.8 
 
2 1 2.5 1.4 0.0052 
 
M P 
     
Lrr 
 
Ig 
IPI00342158 Nuclear pore membrane glycoprotein 210 3.4 3.3 13 10 8 6.5 0.0092 0.0364 M 
   
N 
     
 
UPREGULATED 
                  
IPI00387201 Tumor necrosis factor receptor superfamily member 19 0.3 0.2 4 3 13.2 10.8 1.8E-16 1.9E-15 M P 
 
X 
      
IPI00130804 Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase 0.2 
 
2 1 8 3.4 4.8E-18 
 
M 
         
IPI00399440 Rapamycin-insensitive companion of mTOR 
 
0.1 1 2 1 2 
 
4.1E-30 
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Ratio is shown as the fold downregulation, calculated by Mascot (Mct) or Andromeda (Adr). 'Peptides' refers to total unique or razor peptides. 
Significance A values were calculated by MaxQuant or Perseus. For a given protein, GOCC annotations are shown : M (membrane), P (plasma 
membrane), C (cell surface), X (extracellular), N (nucleus) and S (short GO term). Structural features were determined by literature search and 
Interpro release 34.0 - beta-propeller ( P), leucine rich repeat (Lrr), EGF or EGF-like domain (Egf), immunoglobulin or immunoglobulin-like 
domain (Ig). Other abbreviations –Fibronectin (Fn). We performed this experiment as a single replicate. Confirmation by flow cytometry used at 
least three biological replicates (Figure 3). 
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 SYNOPSIS TOC  
Gp96 is an endoplasmic reticulum chaperone required for cell surface expression of integrins and toll-
like receptors. We combined selective cell surface biotinylation and SILAC in gp96-deficient and gp96-
reconstituted cells to identify the repertoire of cell surface receptors chaperoned by gp96. We report 
novel gp96 clients including four of the ten members of the extended LDL receptor family. Common 
structural motifs amongst clients include the beta-propeller and leucine rich repeat. 
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